Medicine
 |
|
25 may 2019 00:01:05 |
| Feasibility of using NF1-GRD and AAV for gene replacement therapy in NF1-associated tumors (Gene Therapy) |
|
Tweet |
| 89 viewsCategory: Genetics, Medicine |
 AAV-encoded CaV2.2 peptide aptamer CBD3A6K for primary sensory neuron-targeted treatment of established neuropathic pain (Gene Therapy)Bringing balance to the force-regulatable gene therapy for epilepsy (Gene Therapy) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
